Christopher D. Alafi

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Berkeley, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Lawrence J. Hineline, Attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Christopher D. Alafi

Form 4 holding Director

Intra-Cellular Therapies, Inc.

Security class
Common Stock
Shares / value
4,743,770
Estimated value
$314,274,763
Report date
27 May 2021
Price
$66.25
Ownership
Held by Alafi Capital Company, LLC
Form 4 holding Director

Intra-Cellular Therapies, Inc.

Security class
Common Stock
Shares / value
503,753
Estimated value
$33,373,636
Report date
27 May 2021
Price
$66.25
Ownership
Held as Trustee of The Moshe H. Alafi and Margaret E. Alafi Generation-Skipping Trust
Form 4 holding Director

Intra-Cellular Therapies, Inc.

Security class
Common Stock
Shares / value
95,000
Estimated value
$6,293,750
Report date
28 May 2021
Price
$66.25
Ownership
Held by Christopher D Alafi Family Trust

Insider Reports Filed by Christopher D. Alafi

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .